AU570696B2 - Monoclonal antibody to cardiac myosin heavy chain - Google Patents

Monoclonal antibody to cardiac myosin heavy chain

Info

Publication number
AU570696B2
AU570696B2 AU30228/84A AU3022884A AU570696B2 AU 570696 B2 AU570696 B2 AU 570696B2 AU 30228/84 A AU30228/84 A AU 30228/84A AU 3022884 A AU3022884 A AU 3022884A AU 570696 B2 AU570696 B2 AU 570696B2
Authority
AU
Australia
Prior art keywords
heavy chain
monoclonal antibody
myosin heavy
cardiac myosin
cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU30228/84A
Other languages
English (en)
Other versions
AU3022884A (en
Inventor
Masahito Sugi
Yoshio Yazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Publication of AU3022884A publication Critical patent/AU3022884A/en
Application granted granted Critical
Publication of AU570696B2 publication Critical patent/AU570696B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1075Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an enzyme
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU30228/84A 1983-07-06 1984-07-03 Monoclonal antibody to cardiac myosin heavy chain Ceased AU570696B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58122579A JPS6028998A (ja) 1983-07-06 1983-07-06 心筋ミオシン重鎖に対する単一クロ−ン抗体
JP58-122579 1983-07-06

Publications (2)

Publication Number Publication Date
AU3022884A AU3022884A (en) 1985-01-10
AU570696B2 true AU570696B2 (en) 1988-03-24

Family

ID=14839400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30228/84A Ceased AU570696B2 (en) 1983-07-06 1984-07-03 Monoclonal antibody to cardiac myosin heavy chain

Country Status (7)

Country Link
US (1) US4767843A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0131834B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6028998A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR910008637B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU570696B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1225608A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3485965T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
JPH0625762B2 (ja) * 1985-06-13 1994-04-06 ヤマサ醤油株式会社 ミオシン軽鎖の測定法
GB2200358B (en) * 1987-01-27 1991-02-27 Univ Birmingham Materials for in vivo detection of cardiac damage, and methods for their preparation
US5046499A (en) * 1988-06-13 1991-09-10 Centocor, Inc. Method for myocardial infarct risk assessment
DE69019968T2 (de) * 1989-03-28 1995-10-12 Yamasa Shoyu Kk Antikörper gegen die schwere kette eines glatt-muskel-myosins.
US5830720A (en) * 1989-04-21 1998-11-03 Boehringer Mannheim Gmbh Recombinant DNA and expression vector for the repressible and inducible expression of foreign genes
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
DE69531059T2 (de) * 1994-10-25 2004-05-06 Yamasa Corp., Chishi Antikörperreagens zum aufspüren des aneurysma dissecans der aorta sowie dessen verwendung
US6270744B1 (en) * 1996-02-19 2001-08-07 Yamasa Corporation Diagnostic agent for angiopathic diseases
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same

Also Published As

Publication number Publication date
CA1225608A (en) 1987-08-18
EP0131834A3 (en) 1987-06-24
AU3022884A (en) 1985-01-10
DE3485965T2 (de) 1993-03-18
US4767843A (en) 1988-08-30
KR850001282A (ko) 1985-03-18
KR910008637B1 (ko) 1991-10-19
EP0131834B1 (en) 1992-10-28
JPH0231958B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-07-17
EP0131834A2 (en) 1985-01-23
DE3485965D1 (de) 1992-12-03
JPS6028998A (ja) 1985-02-14

Similar Documents

Publication Publication Date Title
AU570696B2 (en) Monoclonal antibody to cardiac myosin heavy chain
GB8422653D0 (en) Monoclonal antibodies
GB8426467D0 (en) Monoclonal antibodies
GB8426463D0 (en) Monoclonal antibodies
GB8422650D0 (en) Monoclonal antibodies
AU7912887A (en) Monoclonal antibodies to fibrin
GB2146351B (en) Monoclonal antibody
EP0159025A3 (en) Monoclonal antibody specific to human alpha2-plasmin
GB2163178B (en) Novel monoclonal antibody
AU3812485A (en) Monoclonal antibody to activated macrophages
GB8426461D0 (en) Monoclonal antibodies
GB8426464D0 (en) Monoclonal antibodies
GB8422651D0 (en) Monoclonal antibodies
GB8426468D0 (en) Monoclonal antibodies
GB8422649D0 (en) Monoclonal antibodies
AU618720B2 (en) Monoclonal antibodies
GB8426459D0 (en) Monoclonal antibodies
GB8426465D0 (en) Monoclonal antibodies
GB8419456D0 (en) Monoclonal antibodies
GB8426460D0 (en) Monoclonal antibodies
GB8426469D0 (en) Monoclonal antibodies
GB8416845D0 (en) Monoclonal antibodies
GB8322310D0 (en) Monoclonal antibodies
GB8426466D0 (en) Monoclonal antibodies
GB8313613D0 (en) Monoclonal antibody to aph-11

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired